This inventor holds 1 USPTO granted patent. Top assignee: Ortho Diagnostic Systems Inc.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Nina T Rubin: Innovator in Disease Diagnosis
Introduction
Nina T Rubin is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of diseases related to kidney function. Her innovative work has led to the development of a patented method that enhances disease diagnosis.
Latest Patents
Nina T Rubin holds a patent titled "Disease diagnosis by detection of shed normal tissue antigens." This patent focuses on methods for detecting diseases caused by proximal convoluted tubule dysfunction or monitoring harmful drug effects on the kidneys. The method involves detecting the presence of shed normal proximal tubule-associated antigens in body fluids, such as urine. The preferred embodiment of this invention employs an ELISA sandwich format, utilizing monoclonal antibodies to identify specific epitopic sites on the antigens.
Career Highlights
Nina has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Ortho Diagnostic Systems Inc., where she continues to work on advancing diagnostic technologies. Her expertise and dedication have positioned her as a valuable contributor to medical science.
Collaborations
Nina T Rubin has collaborated with notable colleagues, including Russell E Thompson and Robert H Rubin. These partnerships have fostered a collaborative environment that enhances the development of innovative diagnostic solutions.
Conclusion
Nina T Rubin's contributions to disease diagnosis through her patented methods exemplify her commitment to improving medical diagnostics. Her work not only advances scientific understanding but also has the potential to significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
